Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-000377
Filing Date
2020-01-02
Accepted
2020-01-02 16:34:45
Documents
1
Period of Report
2020-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm1927374d11_3.html 3  
1 OWNERSHIP DOCUMENT tm1927374d11_3.xml 3 8725
  Complete submission text file 0001104659-20-000377.txt   10261
Mailing Address C/O BIOCANCELL THERAPEUTICS, INC. 8 HARTOM ST. JERUSALEM L3 97775
Business Address
Burgin Jonathan (Reporting) CIK: 0001519448 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38807 | Film No.: 20501944

Mailing Address 1/3 HIGH-TECH VILLAGE GIVAT RAM, P.0. BOX 39264 JERUSALEM L3 9139102
Business Address 1/3 HIGH-TECH VILLAGE GIVAT RAM, P.0. BOX 39264 JERUSALEM L3 9139102 972-2-5486555
Anchiano Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations